On January 2, the benchmark indices concluded the day in negative territory, with Nifty closing around 21,650, as selling pressure affected various sectors except for pharmaceutical and metal stocks. After an initial decline, the market continued to experience losses throughout the day. However, buying at lower levels provided some relief by mitigating some of the losses. In terms of sectors, the pharmaceutical index registered a 2.5% increase, while the auto, realty, capital goods, bank, and IT sectors witnessed a 1% decline each.
NIFTY: The index opened flat at 21,751 and made a high of 21,755 before closing at 21,665. Nifty has formed a bearish candlestick pattern on the daily charts. Its immediate resistance level is now placed at 21,720 while immediate support is at 21,600.
BANK NIFTY: The index opened 40 points lower at 48,194 and closed at 47,761. Bank Nifty has formed a long bearish candlestick pattern on the daily chart. Its immediate resistance level is now placed at 47,900 while support is at 47,500.
Stocks in Spotlight
▪ NMDC: Stock gained 2.8% after the company increased prices of lump ores and fines. Its production in 2023 also rose 18% from 2022 levels.
▪ Alembic Pharma: Stock surged 3.5% after the company received 196 ANDA approvals from USFDA for tentative or final products during the December quarter.
▪ Vodafone Idea: Stock went down 5.59% after the company denied reports saying it was in talks with Elon Musk-promoted Starlink to manage its services in India.
▪ Gold prices gained on Tuesday, boosted by expectations of an easing of monetary policy by the US Federal Reserve in 2024 as investors look forward to a slew of economic data this week that could shed more light on the timing of rate cuts.
▪ European stocks slipped into the red on Tuesday afternoon, shortly after the regional benchmark hit its highest level in nearly two years.
▪ The dollar rose on the first trading day of the year, supported by higher US yields as attention turned to US jobs data and European inflation numbers this week, which may provide clues on central banks’ next moves.
This document has been issued by Liquide Solutions Private Limited for information purposes only and should not be construed as
i) an offer or recommendation to buy or sell securities, commodities, currencies or other investments referred to herein; or
ii) an offer to sell or a solicitation or an offer for the purchase of any of the baskets of Liquide Solutions; or
iii) investment research or investment advice. It does not have regard to specific investment objectives, financial situation and the particular needs of any specific person who may receive this document. Investors should seek personal and independent advice regarding the appropriateness of investing in any of the funds, securities, other investment, or investment strategies that may have been discussed or referred to herein and should understand that the views regarding future prospects may or may not be realized. In no event shall Liquide Life Private Limited and/or its affiliates or any of their directors, trustees, officers and employees be liable for any direct, indirect, special, incidental or consequential damages arising out of the use of information/opinion herein.
With Liquide, you can explore stocks, trade securely in your own broker account, and receive expert-recommended trade setups. Stay updated with real-time tracking, market commentary, and AI-powered insights from LiMo, our intelligent bot. Whether you're a seasoned investor or a newbie, Liquide provides the tools you need to discover your next big investment opportunity. Download the app now from Google Play Store and Apple App Store to revolutionize your investment journey. Don't miss out on the chance to level up your investing game with Liquide.